CeraVe
Dermatological skincare
Affordable dermatologist-developed skincare built on ceramides — cleansers, moisturisers and sunscreens — sold in pharmacies and mass retail in over 100 countries.
Dermatological skincareSince 2005
How it started
Bought from Valeant.
$1.3Bpaid by L'Oréal in 2017
L'Oréal bought CeraVe from Valeant in 2017, together with AcneFree and Ambi, for $1.3B in cash.
How big it is
How big is CeraVe?
€2B+Annual salesFY2024
100+Countries
90,000Dermatologists recommending it
Its place in L'Oréal
Two-billion-euro brand in Dermatological Beauty.
CeraVe is a main growth brand of the Dermatological Beauty Division and L'Oréal's route into mass-priced dermatology skincare.
Who it competes with
CCetaphilNNeutrogenaEEucerinAAveeno
What L'Oréal does not disclose
- CeraVe sales in FY2025 (only the 2-billion-euro threshold in 2024 is stated)
- Brand share of group sales
- Price for CeraVe alone (the $1.3B covered three brands)
- L'Oréal does not report this brand's share of group sales (only its division)
The group behind itL'Oréal
→
Sources
Every number on this page comes from L'Oréal's own reports.
Point your phone at a logo.
See the company behind it.
The full story in 12 chapters · compare any two companies · 335 companies, and any other on request.
Download on the App Store
